Clinical Trials · NCT07275697
Waiting on Atrial Fibrillation Intervention Therapy (WAIT) Study
- Phase
- Phase 4
- Recruitment status
- Recruiting
- Sponsor
- Emma Svennberg
- Enrollment
- 200
- Start date
- Mar 2026
- Locations
- 1 site, Sweden
- Primary endpoint
- Arrhythmia-free survival at 12 months after catheter ablation, excluding the 3-month blanking period, with recurrence defined as any ILR-detected AF, atrial flutter, or atrial tachycardia ≥30 seconds.